Independent Association of Serum Fibroblast Growth Factor 21 Levels With Impaired Liver Enzymes in Hyperthyroid Patients

Fibroblast growth factor 21 (FGF21) is identified as a potential biomarker for liver diseases. However, information is limited regarding serum FGF21 and impaired liver function in hyperthyroidism. We aim to determine the potential association of serum FGF21 levels with impaired liver enzymes in hype...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Fangsen, Zeng, Jinyang, Huang, Peiying, Yan, Bing, Zeng, Xin, Liu, Changqin, Shi, Xiulin, Wang, Liying, Song, Haiqu, Lin, Mingzhu, Yang, Shuyu, Li, Zhibin, Li, Xuejun, Liu, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339876/
https://www.ncbi.nlm.nih.gov/pubmed/30692965
http://dx.doi.org/10.3389/fendo.2018.00800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339876/
https://www.ncbi.nlm.nih.gov/pubmed/30692965
http://dx.doi.org/10.3389/fendo.2018.00800

Ejemplares similares